Zobrazeno 1 - 10
of 3 060
pro vyhledávání: '"Passive immunization"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Respiratory syncytial virus (RSV) is the main cause of low respiratory tract infections in infants under one year of age. In the 2023/2024 season, the monoclonal antibody nirsevimab was available to protect children from RSV, and Spain has become one
Externí odkaz:
https://doaj.org/article/bcd3a555ff4a484c8d8e80965f69a4a2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiang Liu, Jia Chao, Huihui Xiao, Jing Chen, Pan Cui, Xiaoqing Wu, Juan Lu, Juan Wang, Chunlin Chen, Xiaoying Zhang, Gaoxiao Xu, Yong Liu
Publikováno v:
Aquaculture Reports, Vol 35, Iss , Pp 102002- (2024)
The antibodies of outer membrane proteins (OMPs) of bacteria have application value in polyvalent passive vaccines. IgY antibodies can be obtained in large quantities and economically from egg yolk, and have the potential to be applied in aquaculture
Externí odkaz:
https://doaj.org/article/95aacb7cdc6849cea0953abe3d1c6540
Autor:
Evan Sawula, Shane Miersch, Eric D. Jong, Chengjin Li, Fang-Yu Chou, Jean Kit Tang, Reza Saberianfar, Jeffrey Harding, Sachdev S. Sidhu, Andras Nagy
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background Immunologically impaired individuals respond poorly to vaccines, highlighting the need for additional strategies to protect these vulnerable populations from COVID-19. While monoclonal antibodies (mAbs) have emerged as promising t
Externí odkaz:
https://doaj.org/article/e59caee950d2466e9ef888001b73da51
Autor:
Sergey N. Avdeev, Vladimir P. Chulanov, Ekaterina I. Alexeeva, Olga A. Aleshina, Aleksey V. Bereznikov, Oleg N. Kotenko, Aleksander M. Lila, Zinaida Yu. Mutovina, Elena N. Parovichnikova, Daria S. Fomina, Nadiya F. Frolova, Alexey O. Shevchenko
Publikováno v:
Терапевтический архив, Vol 95, Iss 8, Pp 722-729 (2023)
On July 3, 2023, an interdisciplinary Council of Experts The burden of COVID-19 in a heterogeneous population of immunocompromised patients post-pandemic realities was held in Moscow with leading experts in pulmonology, rheumatology, hematology, onco
Externí odkaz:
https://doaj.org/article/87994ce57ab2448b9f97ce142a57085f
Autor:
Stefan Bartl, Yuanyun Xie, Nalini Potluri, Ratnesh Kesineni, Katlin Hencak, Louisa Dal Cengio, Katja Balazs, Abid Oueslati, Michela Parth, Nina Salhat, Alberto Siddu, Oskar Smrzka, Francesca Cicchetti, Günther Straffler, Michael R. Hayden, Amber L. Southwell
Publikováno v:
Neurobiology of Disease, Vol 190, Iss , Pp 106376- (2024)
In Huntington disease (HD), the mutant huntingtin (mtHTT) protein is the principal cause of pathological changes that initiate primarily along the cortico-striatal axis. mtHTT is ubiquitously expressed and there is, accordingly, growing recognition t
Externí odkaz:
https://doaj.org/article/4d07a71b09d34d4a99a06f94d8778757
Autor:
V. S. Kaplin
Publikováno v:
Вестник войск РХБ защиты, Vol 6, Iss 2, Pp 137-151 (2023)
Currently, Western pharmaceutical companies have mastered the production of licensed drugs based on transovarial chicken specific antibodies (IgY antibodies) intended for the treatment and prevention of infections caused by Helicobacter pylori, influ
Externí odkaz:
https://doaj.org/article/a8fc8f728d8a4966b1ba29907da191f4
Publikováno v:
Терапевтический архив, Vol 95, Iss 3, Pp 243-247 (2023)
Background. Chronic obstructive pulmonary disease (COPD) is characterized by a high level of morbidity and mortality and is associated with significant social and economic damage to the health system and society. COPD and COVID-19 have many potential
Externí odkaz:
https://doaj.org/article/4ab316afbdab4977bb58ebb14cc42366
Autor:
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, Sonia Martín-Pérez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Mariarita Sciume, Jorge Labrador, Raul Cordoba, Alberto López-García, Nicola S. Fracchiolla, Francesca Farina, Emanuele Ammatuna, Antonella Cingolani, Daniel García-Bordallo, Stefanie K. Gräfe, Yavuz M. Bilgin, Michelina Dargenio, Tomás José González-López, Anna Guidetti, Tobias Lahmer, Esperanza Lavilla-Rubira, Gustavo-Adolfo Méndez, Lucia Prezioso, Martin Schönlein, Jaap Van Doesum, Dominik Wolf, Ditte Stampe Hersby, Ferenc Magyari, Jens Van Praet, Verena Petzer, Carlo Tascini, Iker Falces-Romero, Andreas Glenthøj, Oliver A. Cornely, Livio Pagano
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-5 (2023)
Abstract Only few studies have analyzed the efficacy of tixagevimab/cilgavimab to prevent severe Coronavirus disease 2019 (COVID-19) and related complications in hematologic malignancies (HM) patients. Here, we report cases of breakthrough COVID-19 a
Externí odkaz:
https://doaj.org/article/8facd03b087449c1b612d97fff8f16a9
Autor:
Shaukat Ali, Elisha Shalim, Farah Farhan, Fatima Anjum, Ayesha Ali, Syed Muneeb Uddin, Faisal Shahab, Mustafa Haider, Iqra Ahmed, Mir Rashid Ali, Sadaf Khan, Sadia Rao, Kabeer Guriro, Saud Elahi, Muhammad Ali, Tehreem Mushtaq, Muneeba Ahsan Sayeed, Sheikh Muhammad Muhaymin, Shoba Luxmi, Saifullah, Saeed Qureshi
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background COVID-19 poses a global health challenge with more than 325 million cumulative cases and above 5 million cumulative deaths reported till January 17, 2022, by the World Health Organization. Several potential treatments to treat COV
Externí odkaz:
https://doaj.org/article/4353a806c36a4999aaf9011843fe4aa4